Mesoridazine (Serentil).
D000437:Alcoholism / Q000188:drug therapy; D001007:Anxiety / Q000188:drug therapy; D001925:Brain Damage, Chronic / Q000188:drug therapy; D002746:Chlorpromazine / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008607:Intellectual Disability / Q000150:complications; D009325:Nausea / Q000139:chemically induced; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy; D012920:Social Behavior Disorders / Q000188:drug therapy; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014202:Tremor / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D010640:Phenothiazines; D014149:Tranquilizing Agents; D013881:Thioridazine; D002746:Chlorpromazine